4/A: IonQ Executive Chair Peter Chapman Corrects Form 4 Filing, Reports Stock Option Exercise and Share Sale
SEC Form 4/A Amendment
Peter Chapman, Executive Chair of IonQ, files an amended Form 4 to correct errors in the original filing regarding stock option exercises and share sales.
Summary
- Peter Chapman, the Executive Chair of IonQ, filed an amended Form 4 with the SEC to correct errors in a previous filing from March 11, 2025.
- The original filing incorrectly reported the exercise of 1,528,394 option shares at $0.13 per share and 471,606 option shares at $7.63 per share.
- The corrected filing states that 2,000,000 option shares were exercised at $0.13 per share, and no shares were exercised at $7.63 per share.
- Chapman also sold 2,000,000 shares of common stock at a weighted average price of $18.7233, with prices ranging from $18.30 to $19.173.
- Following these transactions, Chapman directly owns 414,363 shares of IonQ common stock and 6,096,905 derivative securities.
Sentiment
Score: 5
Explanation: The document is a routine correction of an SEC filing, indicating no significant positive or negative sentiment. It's a factual disclosure of transactions.
Industry Context
This filing is a routine disclosure of insider transactions, which are common for executives of publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Executive compensation packages often include stock options to align management's interests with those of shareholders.
- The exercise of options and subsequent sale of shares is a common practice among executives to diversify their holdings and realize gains.
- The specific details of these transactions, such as the exercise price and sale price, are specific to IonQ and Peter Chapman's individual circumstances.
Stakeholder Impact
- The correction of the filing ensures transparency for shareholders.
- The transactions themselves may have a minor impact on the stock price due to the volume of shares sold.
Key Dates
| Date | Description |
|---|---|
| 03/11/2025 | Date of earliest transaction and original Form 4 filing, which was later amended. |
| 03/11/2025 | Exercise of stock options and sale of common stock. |
| 03/12/2025 | Date of amended Form 4/A filing. |
| 05/16/2029 | Expiration date of stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.